DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Mannstadt M, Clarke BL, Bilezikian JP. et al.
Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism.
J Clin Endocrinol Metab 2019;
104: 5136-5147
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.